Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in Japanese Men: Nationwide J-POPS Multi-institutional Prospective Cohort Study

被引:40
作者
Ohashi, Toshio [1 ]
Yorozu, Atsunori [2 ]
Saito, Shiro [2 ]
Tanaka, Nobumichi [3 ]
Katayama, Norihisa [4 ]
Kojima, Shinsuke [5 ]
Maruo, Shinichiro [5 ]
Kikuchi, Takashi [5 ]
Dokiya, Takushi [6 ]
Fukushima, Masanori [5 ]
Yamanaka, Hidetoshi [7 ]
机构
[1] Keio Univ, Sch Med, Tokyo 1608582, Japan
[2] Natl Hosp Org, Tokyo Med Ctr, Tokyo, Japan
[3] Nara Med Univ, Sch Med, Nara, Japan
[4] Okayama Univ, Sch Med, Okayama 700, Japan
[5] Translat Res Informat Ctr, Kobe, Hyogo, Japan
[6] Kyoundo Hosp, Tokyo, Japan
[7] Kurosawa Hosp, Inst Prevent Med, Gunma, Japan
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2015年 / 93卷 / 01期
关键词
EXTERNAL-BEAM RADIATION; RISK PROSTATE-CANCER; CLINICALLY LOCALIZED ADENOCARCINOMA; VOLUME HISTOGRAM ANALYSIS; PHASE-II TRIAL; INTERMEDIATE-RISK; SEED IMPLANTATION; GASTROINTESTINAL TOXICITY; PREDICTIVE FACTORS; THERAPY;
D O I
10.1016/j.ijrobp.2015.05.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To assess, in a nationwide multi-institutional cohort study begun in 2005 and in which 6927 subjects were enrolled by 2010, the urinary and rectal toxicity profiles of subjects who enrolled during the first 2 years, and evaluate the toxicity profiles for permanent seed implantation (PI) and a combination therapy with PI and external beam radiation therapy (EBRT). Methods and Materials: Baseline data for 2339 subjects out of 2354 patients were available for the analyses. Toxicities were evaluated using the National Cancer Institute's Common Terminology Criteria for Adverse Events, and the International Prostate Symptom Scores were recorded prospectively until 36 months after radiation therapy. Results: Grade 2+ acute urinary toxicities developed in 7.36% (172 of 2337) and grade 2+ acute rectal toxicities developed in 1.03% (24 of 2336) of the patients. Grade 2+ late urinary and rectal toxicities developed in 5.75% (133 of 2312) and 1.86% (43 of 2312) of the patients, respectively. A higher incidence of grade 2+ acute urinary toxicity occurred in the PI group than in the EBRT group (8.49% vs 3.66%; P<.01). Acute rectal toxicity outcomes were similar between the treatment groups. The 3-year cumulative incidence rates for grade 2+ late urinary toxicities were 6.04% versus 4.82% for the PI and the EBRT groups, respectively, with no significant differences between the treatment groups. The 3-year cumulative incidence rates for grade 2+ late rectal toxicities were 0.90% versus 5.01% (P<.01) for the PI and the EBRT groups, respectively. The mean of the postimplant International Prostate Symptom Score peaked at 3 months, but it decreased to a range that was within 2 points of the baseline score, which was observed in 1625 subjects (69.47%) at the 1-year follow-up assessment. Conclusions: The acute urinary toxicities observed were acceptable given the frequency and retention, and the late rectal toxicities were more favorable than those of other studies. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:141 / 149
页数:9
相关论文
共 34 条
[1]   Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy [J].
Albert, M ;
Tempany, CM ;
Schultz, D ;
Chen, MH ;
Cormack, RA ;
Kumar, S ;
Hurwitz, MD ;
Beard, C ;
Tuncali, K ;
O'Leary, M ;
Topulos, GP ;
Valentine, K ;
Lopes, L ;
Kanan, A ;
Kacher, D ;
Rosato, J ;
Kooy, H ;
Jolesz, F ;
Carr-Locke, DL ;
Richie, JP ;
D'Amico, AV .
CANCER, 2003, 98 (05) :949-954
[2]  
[Anonymous], UROL ONCOL
[3]   Long-term urinary sequelae following 125iodine prostate brachytherapy [J].
Crook, Juanita ;
Fleshner, Neil ;
Roberts, Chris ;
Pond, Greg .
JOURNAL OF UROLOGY, 2008, 179 (01) :141-145
[4]   10-YEAR EXPERIENCE WITH I-125 PROSTATE BRACHYTHERAPY AT THE PRINCESS MARGARET HOSPITAL: RESULTS FOR 1,100 PATIENTS [J].
Crook, Juanita ;
Borg, Jette ;
Evans, Andrew ;
Toi, Ants ;
Saibishkumar, E. P. ;
Fung, Sharon ;
Ma, Clement .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (05) :1323-1329
[5]   Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials [J].
Di Maio, Massimo ;
Gallo, Ciro ;
Leighl, Natasha B. ;
Piccirillo, Maria Carmela ;
Daniele, Gennaro ;
Nuzzo, Francesco ;
Gridelli, Cesare ;
Gebbia, Vittorio ;
Ciardiello, Fortunato ;
De Placido, Sabino ;
Ceribelli, Anna ;
Favaretto, Adolfo G. ;
de Matteis, Andrea ;
Feld, Ronald ;
Butts, Charles ;
Bryce, Jane ;
Signoriello, Simona ;
Morabito, Alessandro ;
Rocco, Gaetano ;
Perrone, Francesco .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (08) :910-+
[6]   Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer [J].
Gelblum, DY ;
Potters, L .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01) :119-124
[7]   The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: Morbidity outcomes from two prospective randomized multicenter trials [J].
Ghaly, M ;
Wallner, K ;
Merrick, G ;
True, L ;
Sutlief, S ;
Cavanagh, W ;
Butler, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (05) :1288-1293
[8]   Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group [J].
Grimm, Peter ;
Billiet, Ignace ;
Bostwick, David ;
Dicker, Adam P. ;
Frank, Steven ;
Immerzeel, Jos ;
Keyes, Mira ;
Kupelian, Patrick ;
Lee, W. Robert ;
Machtens, Stefan ;
Mayadev, Jyoti ;
Moran, Brian J. ;
Merrick, Gregory ;
Millar, Jeremy ;
Roach, Mack ;
Stock, Richard ;
Shinohara, Katsuto ;
Scholz, Mark ;
Weber, Ed ;
Zietman, Anthony ;
Zelefsky, Michael ;
Wong, Jason ;
Wentworth, Stacy ;
Vera, Robyn ;
Langley, Stephen .
BJU INTERNATIONAL, 2012, 109 :22-29
[9]   Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: An initial report of CALGB 99809 [J].
Hurwitz, Mark D. ;
Halabi, Susan ;
Ou, San-San ;
McGinnis, Lamar S. ;
Keuttel, Michael R. ;
DiBiase, Steven J. ;
Small, Eric J. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03) :814-819
[10]   Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer [J].
Hurwitz, Mark D. ;
Halabi, Susan ;
Archer, Laura ;
McGinnis, Lamar S. ;
Kuettel, Michael R. ;
DiBiase, Steven J. ;
Small, Eric J. .
CANCER, 2011, 117 (24) :5579-5588